nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0945	0.129	CbGbCtD
Trabectedin—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0819	0.112	CbGbCtD
Trabectedin—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0604	0.0827	CbGbCtD
Trabectedin—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0604	0.0827	CbGbCtD
Trabectedin—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0502	0.0688	CbGbCtD
Trabectedin—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0502	0.0688	CbGbCtD
Trabectedin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0459	0.0629	CbGbCtD
Trabectedin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0459	0.0629	CbGbCtD
Trabectedin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0409	0.056	CbGbCtD
Trabectedin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0385	0.0528	CbGbCtD
Trabectedin—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0381	0.0521	CbGbCtD
Trabectedin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.026	0.0356	CbGbCtD
Trabectedin—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0254	0.0347	CbGbCtD
Trabectedin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0248	0.034	CbGbCtD
Trabectedin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0221	0.0303	CbGbCtD
Trabectedin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.013	0.0178	CbGbCtD
Trabectedin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0123	0.0168	CbGbCtD
Trabectedin—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000642	0.00383	CcSEcCtD
Trabectedin—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.000641	0.00382	CcSEcCtD
Trabectedin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000639	0.00381	CcSEcCtD
Trabectedin—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000633	0.00377	CcSEcCtD
Trabectedin—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000633	0.00377	CcSEcCtD
Trabectedin—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00375	CcSEcCtD
Trabectedin—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.00374	CcSEcCtD
Trabectedin—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00369	CcSEcCtD
Trabectedin—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000619	0.00369	CcSEcCtD
Trabectedin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000618	0.00368	CcSEcCtD
Trabectedin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000613	0.00365	CcSEcCtD
Trabectedin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000613	0.00365	CcSEcCtD
Trabectedin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000613	0.00365	CcSEcCtD
Trabectedin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000611	0.00364	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000609	0.00363	CcSEcCtD
Trabectedin—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00358	CcSEcCtD
Trabectedin—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00358	CcSEcCtD
Trabectedin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000594	0.00354	CcSEcCtD
Trabectedin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000594	0.00354	CcSEcCtD
Trabectedin—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00351	CcSEcCtD
Trabectedin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000589	0.00351	CcSEcCtD
Trabectedin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000588	0.00351	CcSEcCtD
Trabectedin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000587	0.0035	CcSEcCtD
Trabectedin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000585	0.00349	CcSEcCtD
Trabectedin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00348	CcSEcCtD
Trabectedin—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000585	0.00348	CcSEcCtD
Trabectedin—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.00348	CcSEcCtD
Trabectedin—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000584	0.00348	CcSEcCtD
Trabectedin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000582	0.00347	CcSEcCtD
Trabectedin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00346	CcSEcCtD
Trabectedin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00346	CcSEcCtD
Trabectedin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000578	0.00344	CcSEcCtD
Trabectedin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000576	0.00343	CcSEcCtD
Trabectedin—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000573	0.00341	CcSEcCtD
Trabectedin—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.00341	CcSEcCtD
Trabectedin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.0034	CcSEcCtD
Trabectedin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000569	0.00339	CcSEcCtD
Trabectedin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000569	0.00339	CcSEcCtD
Trabectedin—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00338	CcSEcCtD
Trabectedin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000563	0.00336	CcSEcCtD
Trabectedin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000562	0.00335	CcSEcCtD
Trabectedin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.00335	CcSEcCtD
Trabectedin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000555	0.00331	CcSEcCtD
Trabectedin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00329	CcSEcCtD
Trabectedin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00327	CcSEcCtD
Trabectedin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000548	0.00327	CcSEcCtD
Trabectedin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00323	CcSEcCtD
Trabectedin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.0032	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.00319	CcSEcCtD
Trabectedin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000531	0.00317	CcSEcCtD
Trabectedin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00316	CcSEcCtD
Trabectedin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000527	0.00314	CcSEcCtD
Trabectedin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000517	0.00308	CcSEcCtD
Trabectedin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000509	0.00304	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000507	0.00302	CcSEcCtD
Trabectedin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00302	CcSEcCtD
Trabectedin—Cough—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00302	CcSEcCtD
Trabectedin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.00299	CcSEcCtD
Trabectedin—Cough—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00296	CcSEcCtD
Trabectedin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00295	CcSEcCtD
Trabectedin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00295	CcSEcCtD
Trabectedin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00295	CcSEcCtD
Trabectedin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00295	CcSEcCtD
Trabectedin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00293	CcSEcCtD
Trabectedin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00293	CcSEcCtD
Trabectedin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00293	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.00293	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000491	0.00293	CcSEcCtD
Trabectedin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000484	0.00289	CcSEcCtD
Trabectedin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000484	0.00289	CcSEcCtD
Trabectedin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00287	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000481	0.00287	CcSEcCtD
Trabectedin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00048	0.00286	CcSEcCtD
Trabectedin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00285	CcSEcCtD
Trabectedin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00282	CcSEcCtD
Trabectedin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00282	CcSEcCtD
Trabectedin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00281	CcSEcCtD
Trabectedin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00281	CcSEcCtD
Trabectedin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00278	CcSEcCtD
Trabectedin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00278	CcSEcCtD
Trabectedin—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00277	CcSEcCtD
Trabectedin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000465	0.00277	CcSEcCtD
Trabectedin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.00277	CcSEcCtD
Trabectedin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.00277	CcSEcCtD
Trabectedin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000464	0.00277	CcSEcCtD
Trabectedin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00275	CcSEcCtD
Trabectedin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00274	CcSEcCtD
Trabectedin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00274	CcSEcCtD
Trabectedin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00273	CcSEcCtD
Trabectedin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000455	0.00271	CcSEcCtD
Trabectedin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000455	0.00271	CcSEcCtD
Trabectedin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000454	0.0027	CcSEcCtD
Trabectedin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00269	CcSEcCtD
Trabectedin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00267	CcSEcCtD
Trabectedin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00265	CcSEcCtD
Trabectedin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00264	CcSEcCtD
Trabectedin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00264	CcSEcCtD
Trabectedin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.00262	CcSEcCtD
Trabectedin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00262	CcSEcCtD
Trabectedin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00259	CcSEcCtD
Trabectedin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00258	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00257	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00257	CcSEcCtD
Trabectedin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.00256	CcSEcCtD
Trabectedin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000429	0.00256	CcSEcCtD
Trabectedin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00254	CcSEcCtD
Trabectedin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000426	0.00254	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000423	0.00252	CcSEcCtD
Trabectedin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00252	CcSEcCtD
Trabectedin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00252	CcSEcCtD
Trabectedin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00042	0.0025	CcSEcCtD
Trabectedin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00249	CcSEcCtD
Trabectedin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000417	0.00249	CcSEcCtD
Trabectedin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.00249	CcSEcCtD
Trabectedin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00248	CcSEcCtD
Trabectedin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.00245	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00244	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00244	CcSEcCtD
Trabectedin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000409	0.00244	CcSEcCtD
Trabectedin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00244	CcSEcCtD
Trabectedin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00244	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00243	CcSEcCtD
Trabectedin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00242	CcSEcCtD
Trabectedin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00242	CcSEcCtD
Trabectedin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00241	CcSEcCtD
Trabectedin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.0024	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00239	CcSEcCtD
Trabectedin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00239	CcSEcCtD
Trabectedin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00238	CcSEcCtD
Trabectedin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000396	0.00236	CcSEcCtD
Trabectedin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00235	CcSEcCtD
Trabectedin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000393	0.00234	CcSEcCtD
Trabectedin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.00234	CcSEcCtD
Trabectedin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00039	0.00233	CcSEcCtD
Trabectedin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.00232	CcSEcCtD
Trabectedin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00231	CcSEcCtD
Trabectedin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00231	CcSEcCtD
Trabectedin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00231	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.0023	CcSEcCtD
Trabectedin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.0023	CcSEcCtD
Trabectedin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00228	CcSEcCtD
Trabectedin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00226	CcSEcCtD
Trabectedin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00223	CcSEcCtD
Trabectedin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00223	CcSEcCtD
Trabectedin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00223	CcSEcCtD
Trabectedin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00223	CcSEcCtD
Trabectedin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000374	0.00223	CcSEcCtD
Trabectedin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.00221	CcSEcCtD
Trabectedin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.00221	CcSEcCtD
Trabectedin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.0022	CcSEcCtD
Trabectedin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000368	0.00219	CcSEcCtD
Trabectedin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00219	CcSEcCtD
Trabectedin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00219	CcSEcCtD
Trabectedin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00218	CcSEcCtD
Trabectedin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.00216	CcSEcCtD
Trabectedin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.00215	CcSEcCtD
Trabectedin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00211	CcSEcCtD
Trabectedin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00211	CcSEcCtD
Trabectedin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00208	CcSEcCtD
Trabectedin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00208	CcSEcCtD
Trabectedin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00208	CcSEcCtD
Trabectedin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00206	CcSEcCtD
Trabectedin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00204	CcSEcCtD
Trabectedin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00203	CcSEcCtD
Trabectedin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00203	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00199	CcSEcCtD
Trabectedin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00199	CcSEcCtD
Trabectedin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00197	CcSEcCtD
Trabectedin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00193	CcSEcCtD
Trabectedin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00193	CcSEcCtD
Trabectedin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00191	CcSEcCtD
Trabectedin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00189	CcSEcCtD
Trabectedin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00187	CcSEcCtD
Trabectedin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00187	CcSEcCtD
Trabectedin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00183	CcSEcCtD
Trabectedin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00183	CcSEcCtD
Trabectedin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00183	CcSEcCtD
Trabectedin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.0018	CcSEcCtD
Trabectedin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000301	0.0018	CcSEcCtD
Trabectedin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00178	CcSEcCtD
Trabectedin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00178	CcSEcCtD
Trabectedin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00178	CcSEcCtD
Trabectedin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00178	CcSEcCtD
Trabectedin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00177	CcSEcCtD
Trabectedin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00177	CcSEcCtD
Trabectedin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000297	0.00177	CcSEcCtD
Trabectedin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00176	CcSEcCtD
Trabectedin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000295	0.00176	CcSEcCtD
Trabectedin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00174	CcSEcCtD
Trabectedin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00174	CcSEcCtD
Trabectedin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00173	CcSEcCtD
Trabectedin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.0017	CcSEcCtD
Trabectedin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00168	CcSEcCtD
Trabectedin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00168	CcSEcCtD
Trabectedin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00168	CcSEcCtD
Trabectedin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00168	CcSEcCtD
Trabectedin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00168	CcSEcCtD
Trabectedin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00167	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00165	CcSEcCtD
Trabectedin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00164	CcSEcCtD
Trabectedin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00158	CcSEcCtD
Trabectedin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00157	CcSEcCtD
Trabectedin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00156	CcSEcCtD
Trabectedin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00154	CcSEcCtD
Trabectedin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00153	CcSEcCtD
Trabectedin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00151	CcSEcCtD
Trabectedin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00145	CcSEcCtD
Trabectedin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00142	CcSEcCtD
Trabectedin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00138	CcSEcCtD
Trabectedin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00138	CcSEcCtD
Trabectedin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00137	CcSEcCtD
Trabectedin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00137	CcSEcCtD
Trabectedin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00136	CcSEcCtD
Trabectedin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00126	CcSEcCtD
Trabectedin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00122	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000201	0.0012	CcSEcCtD
Trabectedin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00116	CcSEcCtD
Trabectedin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00116	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00115	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00113	CcSEcCtD
Trabectedin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00111	CcSEcCtD
Trabectedin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000185	0.0011	CcSEcCtD
Trabectedin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00109	CcSEcCtD
Trabectedin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00109	CcSEcCtD
Trabectedin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00108	CcSEcCtD
Trabectedin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00106	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00101	CcSEcCtD
Trabectedin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00101	CcSEcCtD
Trabectedin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00101	CcSEcCtD
Trabectedin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000998	CcSEcCtD
Trabectedin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000979	CcSEcCtD
Trabectedin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000966	CcSEcCtD
Trabectedin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000965	CcSEcCtD
Trabectedin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000964	CcSEcCtD
Trabectedin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000958	CcSEcCtD
Trabectedin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000958	CcSEcCtD
Trabectedin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000951	CcSEcCtD
Trabectedin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000909	CcSEcCtD
Trabectedin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000909	CcSEcCtD
Trabectedin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000879	CcSEcCtD
Trabectedin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000879	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000819	CcSEcCtD
Trabectedin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000798	CcSEcCtD
Trabectedin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000761	CcSEcCtD
Trabectedin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000735	CcSEcCtD
Trabectedin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000707	CcSEcCtD
Trabectedin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000701	CcSEcCtD
Trabectedin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000118	0.0007	CcSEcCtD
Trabectedin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000696	CcSEcCtD
Trabectedin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00066	CcSEcCtD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.05e-05	0.000889	CbGpPWpGaD
Trabectedin—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.92e-05	0.000876	CbGpPWpGaD
Trabectedin—SRC—Immune System—RAPGEF3—chronic obstructive pulmonary disease	8.84e-05	0.000868	CbGpPWpGaD
Trabectedin—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.8e-05	0.000864	CbGpPWpGaD
Trabectedin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.8e-05	0.000864	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—VEGFA—chronic obstructive pulmonary disease	8.78e-05	0.000862	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—NOS3—chronic obstructive pulmonary disease	8.75e-05	0.000859	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	8.73e-05	0.000857	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	8.62e-05	0.000846	CbGpPWpGaD
Trabectedin—SRC—Immune System—LY96—chronic obstructive pulmonary disease	8.6e-05	0.000844	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB2—chronic obstructive pulmonary disease	8.4e-05	0.000824	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—VEGFA—chronic obstructive pulmonary disease	8.29e-05	0.000814	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	8.28e-05	0.000813	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.25e-05	0.00081	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—EGFR—chronic obstructive pulmonary disease	8.21e-05	0.000806	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—chronic obstructive pulmonary disease	8.21e-05	0.000806	CbGpPWpGaD
Trabectedin—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.21e-05	0.000806	CbGpPWpGaD
Trabectedin—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.2e-05	0.000805	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	8.18e-05	0.000804	CbGpPWpGaD
Trabectedin—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.14e-05	0.000799	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	8.11e-05	0.000796	CbGpPWpGaD
Trabectedin—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.1e-05	0.000795	CbGpPWpGaD
Trabectedin—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.09e-05	0.000794	CbGpPWpGaD
Trabectedin—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.03e-05	0.000788	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—EGFR—chronic obstructive pulmonary disease	8.02e-05	0.000788	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	7.84e-05	0.00077	CbGpPWpGaD
Trabectedin—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.77e-05	0.000763	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.74e-05	0.00076	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.74e-05	0.000759	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	7.71e-05	0.000757	CbGpPWpGaD
Trabectedin—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.67e-05	0.000753	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.65e-05	0.000751	CbGpPWpGaD
Trabectedin—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.54e-05	0.000741	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HDAC2—chronic obstructive pulmonary disease	7.53e-05	0.000739	CbGpPWpGaD
Trabectedin—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.48e-05	0.000734	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.47e-05	0.000733	CbGpPWpGaD
Trabectedin—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.44e-05	0.00073	CbGpPWpGaD
Trabectedin—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.38e-05	0.000724	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.19e-05	0.000706	CbGpPWpGaD
Trabectedin—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.15e-05	0.000702	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	7.15e-05	0.000702	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	7.13e-05	0.0007	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.13e-05	0.0007	CbGpPWpGaD
Trabectedin—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.09e-05	0.000696	CbGpPWpGaD
Trabectedin—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.05e-05	0.000692	CbGpPWpGaD
Trabectedin—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.99e-05	0.000686	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	6.99e-05	0.000686	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	6.82e-05	0.000669	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PLAUR—chronic obstructive pulmonary disease	6.79e-05	0.000667	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	6.74e-05	0.000661	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—TLR2—chronic obstructive pulmonary disease	6.7e-05	0.000658	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.5e-05	0.000638	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.000632	CbGpPWpGaD
Trabectedin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.35e-05	0.000623	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	6.34e-05	0.000622	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KL—chronic obstructive pulmonary disease	6.3e-05	0.000619	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.25e-05	0.000614	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	6.17e-05	0.000605	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	6.08e-05	0.000596	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KL—chronic obstructive pulmonary disease	6.05e-05	0.000594	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.75e-05	0.000565	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	5.73e-05	0.000563	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.72e-05	0.000561	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.7e-05	0.00056	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	5.7e-05	0.00056	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	5.67e-05	0.000557	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	5.67e-05	0.000557	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	5.64e-05	0.000554	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—chronic obstructive pulmonary disease	5.61e-05	0.000551	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—VEGFA—chronic obstructive pulmonary disease	5.55e-05	0.000545	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.53e-05	0.000542	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.37e-05	0.000527	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.37e-05	0.000527	CbGpPWpGaD
Trabectedin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.29e-05	0.00052	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	5.28e-05	0.000519	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	5.24e-05	0.000514	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	5.22e-05	0.000513	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	5.19e-05	0.00051	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.18e-05	0.000508	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	5.17e-05	0.000507	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.07e-05	0.000498	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—chronic obstructive pulmonary disease	4.99e-05	0.00049	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.97e-05	0.000488	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.93e-05	0.000484	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	4.92e-05	0.000483	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	4.88e-05	0.000479	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	4.87e-05	0.000478	CbGpPWpGaD
Trabectedin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.86e-05	0.000478	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.86e-05	0.000477	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—MMP1—chronic obstructive pulmonary disease	4.85e-05	0.000476	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.79e-05	0.00047	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PLAU—chronic obstructive pulmonary disease	4.76e-05	0.000468	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.74e-05	0.000465	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	4.72e-05	0.000464	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	4.68e-05	0.00046	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000459	CbGpPWpGaD
Trabectedin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.61e-05	0.000453	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	4.54e-05	0.000445	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.51e-05	0.000443	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.46e-05	0.000438	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	4.38e-05	0.00043	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.38e-05	0.00043	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	4.36e-05	0.000428	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	4.34e-05	0.000426	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.33e-05	0.000425	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CRP—chronic obstructive pulmonary disease	4.32e-05	0.000424	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.17e-05	0.00041	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.14e-05	0.000407	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—TLR4—chronic obstructive pulmonary disease	4.14e-05	0.000407	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.11e-05	0.000403	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.07e-05	0.000399	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	4.06e-05	0.000399	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.03e-05	0.000396	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.03e-05	0.000396	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	4.03e-05	0.000395	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	3.99e-05	0.000392	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	3.97e-05	0.00039	CbGpPWpGaD
Trabectedin—SRC—Immune System—TLR2—chronic obstructive pulmonary disease	3.9e-05	0.000383	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.82e-05	0.000375	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.81e-05	0.000374	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.78e-05	0.000371	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.78e-05	0.000371	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.76e-05	0.000369	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.75e-05	0.000368	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.75e-05	0.000368	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.71e-05	0.000364	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.68e-05	0.000362	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ALB—chronic obstructive pulmonary disease	3.68e-05	0.000361	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.68e-05	0.000361	CbGpPWpGaD
Trabectedin—SRC—Immune System—KL—chronic obstructive pulmonary disease	3.67e-05	0.00036	CbGpPWpGaD
Trabectedin—SRC—Disease—HDAC2—chronic obstructive pulmonary disease	3.65e-05	0.000358	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.62e-05	0.000355	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.6e-05	0.000353	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.6e-05	0.000353	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.52e-05	0.000346	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.52e-05	0.000345	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.49e-05	0.000343	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.45e-05	0.000338	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.44e-05	0.000338	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.42e-05	0.000335	CbGpPWpGaD
Trabectedin—SRC—Disease—KL—chronic obstructive pulmonary disease	3.39e-05	0.000333	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.26e-05	0.00032	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.17e-05	0.000312	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.99e-05	0.000293	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD8A—chronic obstructive pulmonary disease	2.96e-05	0.00029	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.88e-05	0.000282	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.85e-05	0.00028	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.82e-05	0.000277	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.77e-05	0.000272	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB3—chronic obstructive pulmonary disease	2.75e-05	0.00027	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.000267	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.00026	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.61e-05	0.000256	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.58e-05	0.000254	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.57e-05	0.000253	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.55e-05	0.000251	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB3—chronic obstructive pulmonary disease	2.54e-05	0.000249	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.53e-05	0.000249	CbGpPWpGaD
Trabectedin—SRC—Immune System—CRP—chronic obstructive pulmonary disease	2.52e-05	0.000247	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—IL6—chronic obstructive pulmonary disease	2.5e-05	0.000246	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.49e-05	0.000245	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000239	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.42e-05	0.000238	CbGpPWpGaD
Trabectedin—SRC—Immune System—TLR4—chronic obstructive pulmonary disease	2.41e-05	0.000237	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.37e-05	0.000233	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.37e-05	0.000233	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.37e-05	0.000233	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.33e-05	0.000228	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.32e-05	0.000228	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000226	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.25e-05	0.000221	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.21e-05	0.000217	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.2e-05	0.000216	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.19e-05	0.000215	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.18e-05	0.000214	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—chronic obstructive pulmonary disease	2.12e-05	0.000208	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.05e-05	0.000202	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.03e-05	0.000199	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.03e-05	0.000199	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.01e-05	0.000197	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2e-05	0.000197	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.000195	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000195	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.98e-05	0.000194	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.97e-05	0.000194	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.96e-05	0.000192	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.95e-05	0.000192	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—chronic obstructive pulmonary disease	1.91e-05	0.000188	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000182	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.83e-05	0.00018	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000179	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.82e-05	0.000178	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000178	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.79e-05	0.000175	CbGpPWpGaD
Trabectedin—SRC—Disease—SERPINE1—chronic obstructive pulmonary disease	1.78e-05	0.000175	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.78e-05	0.000175	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000169	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.71e-05	0.000168	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS3—chronic obstructive pulmonary disease	1.7e-05	0.000167	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.000164	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.59e-05	0.000156	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.58e-05	0.000155	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL1B—chronic obstructive pulmonary disease	1.57e-05	0.000154	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.00015	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000148	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000147	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.4e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000137	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000136	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000135	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000131	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.32e-05	0.00013	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000128	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000127	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000126	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.25e-05	0.000123	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.00012	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000119	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000117	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000115	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—chronic obstructive pulmonary disease	1.13e-05	0.000111	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.00011	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—chronic obstructive pulmonary disease	1.1e-05	0.000108	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000108	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000104	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.57e-06	9.39e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—chronic obstructive pulmonary disease	9.19e-06	9.02e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.18e-06	9.01e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.05e-06	8.89e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	9.04e-06	8.87e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.65e-06	8.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.59e-06	8.44e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—chronic obstructive pulmonary disease	8.49e-06	8.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.43e-06	8.28e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.31e-06	8.16e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.24e-06	8.09e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8e-06	7.85e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.95e-06	7.81e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.89e-06	7.74e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.88e-06	7.74e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.73e-06	7.59e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.49e-06	6.37e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.94e-06	5.83e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.43e-06	5.34e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.2e-06	5.1e-05	CbGpPWpGaD
